Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by ROSENKRANZ, A. R.
Right arrow Articles by ZLABINGER, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by ROSENKRANZ, A. R.
Right arrow Articles by ZLABINGER, G. J.
J Am Soc Nephrol 10:128-135, 1999
© 1999 American Society of Nephrology


REGULAR ARTICLES

Novel C5-Dependent Mechanism of Neutrophil Stimulation by Bioincompatible Dialyzer Membranes

ALEXANDER R. ROSENKRANZ*, GÜNTHER F. KÖRMÖCZI*, FLORIAN THALHAMMER{dagger}, ERNST J. MENZEL{ddagger}, WALTER H. HÖRL*, GERT MAYER* and GERHARD J. ZLABINGER{ddagger}

* Department of Internal Medicine III, Division of Nephrology and Dialysis, University of Vienna, Austria.
{dagger} Department of Internal Medicine I, University of Vienna, Austria.
{ddagger} Institute of Immunology, University of Vienna, Austria.

Correspondence to Dr. Gerhard J. Zlabinger, Institute of Immunology, Borschkegasse 8a, A-1090 Vienna, Austria. Phone: 43-1-40154-356; Fax: 43-1-4086670; E-mail: Gerhard-Johann.Zlabinger{at}univie.ac.at

Abstract. The objective of the study was to evaluate the contribution of reactive oxygen intermediate formation for receptor modulation on neutrophils by the cellulosic dialyzer membrane cuprophan (CU). In patients dialyzed with CU, CD11b and CD66b upregulation on neutrophils (by 104.3 ± 37.9% and 85.7 ± 31.1%, respectively), and a downregulation of L-selectin (by 44.9 ± 26.9%) was seen, whereas expression of CD11 a remained unaltered. Hemodialysis with polysulfone did not bring about major changes in surface receptor expression. In vitro incubation of isolated neutrophils in the presence of serum with hollow fibers of CU or polysulfone showed similar results: Only CU resulted in upregulation of CD11b and CD66b expression (by 65.5 ± 18.7% and 60.1 ± 24%) and a decrease in CD62L expression (by 60.6 ± 18.2%). In contrast to receptor alterations, generation of reactive oxygen intermediate by CU occurred in the absence of serum. Inhibition experiments with soluble complement receptor 1, which produced only partial inhibition of receptor up-/down-regulation, indicated the existence of also other than alternate complement-dependent mechanisms for neutrophil activation. By using C5-depleted serum instead of normal human serum, up-/down-regulation of CD11b, CD62L, and CD66b by CU was dramatically reduced, whereas C3-depleted serum did not produce that effect. C5-deficient serum repleted with purified C5, as well as purified C5 alone, was able to induce receptor modulation by CU comparable to normal human serum. L-Methionine, a specific inhibitor for the oxidative activation of C5, blocked the modulatory effect of CU in assays with purified C5 as well as with serum. As a result, in addition to the alternative pathway of complement, a C5-dependent mechanism probably activated by neutrophil-derived reactive oxygen intermediate leads to receptor modulation and subsequent generation of the well known side effects of bioincompatible dialyzer membranes.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
H. Koller, K. Hochegger, G. J. Zlabinger, K. Lhotta, G. Mayer, and A. R. Rosenkranz
Apoptosis of human polymorphonuclear neutrophils accelerated by dialysis membranes via the activation of the complement system
Nephrol. Dial. Transplant., December 1, 2004; 19(12): 3104 - 3111.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
W. H. Horl
Hemodialysis Membranes: Interleukins, Biocompatibility, and Middle Molecules
J. Am. Soc. Nephrol., January 1, 2002; 13(90001): S62 - 71.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. F. Kormoczi, U. M. Wolfel, A. R. Rosenkranz, W. H. Horl, R. Oberbauer, and G. J. Zlabinger
Serum Proteins Modified by Neutrophil-Derived Oxidants as Mediators of Neutrophil Stimulation
J. Immunol., July 1, 2001; 167(1): 451 - 460.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP